肝细胞肝癌合并微血管癌栓的研究进展

Research progress of microvascular invasion in hepatocellular carcinoma

  • 摘要: 肝细胞肝癌(简称肝癌)是常见的恶性肿瘤之一,即使行根治性手术治疗,预后依然较差。微血管癌栓(MVI)是一种恶性的肿瘤生物学行为,是影响肝癌根治术后肿瘤复发与患者生存最重要的原因,已越来越受到临床医师的关注和重视。早期识别MVI发生,并选择合理方法及早干预,将有望减少患者术后肿瘤复发,提高远期生存率。笔者就肝癌合并MVI的研究进展进行综述。

     

    Abstract: Hepatocellular carcinoma is one of the most common malignancies in the worldwide. Selected patients with hepatocellular carcinoma are candidates for curative resection, but nevertheless there is a high risk of tumor recurrence. Microvascular invasion (MVI) is an aggressive biological behavior and has repeatedly been identified as a risk factor for prognosis after curative treatment, meanwhile, it is now becoming increasingly concerned . It would be of great significance to distinguish MVI in an early stage and choose an appropriate treatment timely to get a definite improvement for the longterm survival in patients with hepatocellular carcinoma after curative treatment. This review focuses on some certain issues of MVI.

     

/

返回文章
返回